Athersys is an Ohio-based biotechnology firm that develops and researches stem cell therapeutics for the treatment of neurological and cardiovascular diseases...
Read moreAthersys is an Ohio-based biotechnology firm that develops and researches stem cell therapeutics for the treatment of neurological and cardiovascular diseases...
Read more1995
PublicIndependent CompanyNASDAQATHX
Annual Revenue
$6M
Athersys's revenue is the ranked 20th among it's top 10 competitors. The top 10 competitors average 1.1B. Over the last four quarters, Athersys's revenue has decreased by 91%. Specifically, in Q3 2022's revenue was $ < 1M; in Q2 2022, it was $2.3M; in Q1 2022, it was $2.9M; in Q4 2021, Athersys's revenue was $ < 1M.